RedHill Biopharma (RDHL) Current Assets (2012 - 2026)
RedHill Biopharma (RDHL) posted Current Assets of $8.57 million for the quarter ended Jun 30, 2026, down 31.7% from $12.56 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Current Assets (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma's Current Assets came in at $6.53 million, down 45.2% from the prior year.
- Annual Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -37.9% (years ended Dec 2020 to Dec 2025).
- In prior years, RedHill Biopharma's Current Assets was $11.91 million in the year ended Dec 31, 2024 (-26.2%), $16.14 million in the year ended Dec 31, 2023 (-81.2%), $85.9 million in the year ended Dec 31, 2022 (-3.6%) and $89.15 million in the year ended Dec 31, 2021 (+26.5%).
- Quarterly Current Assets has run from a low of $6.53 million in the quarter ended Dec 31, 2025 to a high of $91.27 million in the quarter ended Jun 30, 2022 over five years.
- The strongest year-over-year quarter for Current Assets in the past five years was the quarter ended Dec 31, 2021, with growth of 26.5%; the weakest was the quarter ended Dec 31, 2023, with a decline of 81.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - | 8.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.57 Mn |
| Dec 31, 2025 | 6.53 Mn |
| Jun 30, 2025 | 12.56 Mn |
| Dec 31, 2024 | 11.91 Mn |
| Jun 30, 2024 | 15.70 Mn |
| Dec 31, 2023 | 16.14 Mn |
| Jun 30, 2023 | 27.05 Mn |
| Dec 31, 2022 | 85.90 Mn |
| Jun 30, 2022 | 91.27 Mn |
| Dec 31, 2021 | 89.15 Mn |
| Jun 30, 2021 | 98.49 Mn |
| Dec 31, 2020 | 70.50 Mn |
| Jun 30, 2020 | 61.13 Mn |
| Dec 31, 2019 | 53.21 Mn |
| Jun 30, 2019 | 39.97 Mn |
| Dec 31, 2018 | 56.79 Mn |
| Jun 30, 2018 | 32.22 Mn |
| Mar 31, 2018 | 40.74 Mn |
| Dec 31, 2017 | 51.68 Mn |
| Dec 31, 2016 | 67.82 Mn |
API Access
RedHill Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();